In conclusion, AM alleviated acquired hyperlipidemia in mice fed with HFD through regulating lipid metabolism, and AKT1, VEGFA, CCND1 and ESR1 may be the key targets. The gene discussed is CCND1; the disease is hyperlipidemia.